SCHEMBL6318625

SCHEMBL6318625

COc1cc(C2(P3(=O)CCCCC3)CCCCC2Nc2nc(C)cc(C)n2)ccc1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.37
PTPN7 P35236 2/20 0.34
DUSP3 P51452 2/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
GAA P10253 3/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
PIK3CA P42336 3/20 0.33
HTT P42858 3/20 0.32
GFER P55789 1/20 0.31
USP2 O75604 1/20 0.31
HRH2 P25021 1/20 0.31
TRPC5 Q9UL62 1/20 0.31
STK17B O94768 1/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318685 0.73 GAA (0.31) PTPN7DUSP3LMNAMAPTALDH1A1
SCHEMBL6319727 0.71 SLC6A2 (0.31) SLC6A2SLC6A4SLC6A3
SCHEMBL6319604 0.70 HRH2 (0.31) HRH2TRPC5
SCHEMBL31615373 0.61 SLC6A4 (0.49) LMNASLC6A2SLC6A4SLC6A3
SCHEMBL31615412 0.61 SLC6A4 (0.49) LMNASLC6A2SLC6A4SLC6A3
SCHEMBL31615376 0.61 SLC6A4 (0.49) LMNASLC6A2SLC6A4SLC6A3
SCHEMBL21882883 0.60 LMNA (0.57) TP53LMNAMAPTALDH1A1HPGD
SCHEMBL31615399 0.60 SLC6A4 (0.48) PTPN7DUSP3LMNAMAPTALDH1A1
SCHEMBL23787921 0.59 LMNA (0.48) DUSP3LMNAALDH1A1HPGDGFER
SCHEMBL4961835 0.58 CASP1 (0.49) TP53LMNAMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US claimed
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels APOB, LDLR, LPL TP53 3677/4885PTPN7 988/4885DUSP3 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.